Is Elimination of Hepatitis B and C a Pipe Dream or Reality? - PubMed (original) (raw)

. 2019 Jan;156(2):294-296.

doi: 10.1053/j.gastro.2018.12.015. Epub 2018 Dec 26.

Affiliations

• PMID: 30593764
• DOI: 10.1053/j.gastro.2018.12.015

Is Elimination of Hepatitis B and C a Pipe Dream or Reality?

Harvey J Alter et al. Gastroenterology. 2019 Jan.

No abstract available

PubMed Disclaimer

Similar articles

• Progress towards elimination goals for viral hepatitis.
  Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, Zoulim F. Cox AL, et al. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):533-542. doi: 10.1038/s41575-020-0332-6. Epub 2020 Jul 23. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32704164 Free PMC article.
• What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
  Ward JW, Hinman AR. Ward JW, et al. Gastroenterology. 2019 Jan;156(2):297-310. doi: 10.1053/j.gastro.2018.10.048. Epub 2018 Nov 2. Gastroenterology. 2019. PMID: 30391470 Review.
• New WHO guidance for country validation of viral hepatitis B and C elimination.
  Easterbrook P, Luhmann N, Newman M, Walsh N, Lesi O, Doherty M. Easterbrook P, et al. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):778-780. doi: 10.1016/S2468-1253(21)00267-3. Epub 2021 Aug 9. Lancet Gastroenterol Hepatol. 2021. PMID: 34384530 No abstract available.
• Eliminating hepatitis from the Eastern Mediterranean Region.
  Fikri M. Fikri M. East Mediterr Health J. 2017 Aug 27;23(7):459-460. East Mediterr Health J. 2017. PMID: 28853128 No abstract available.
• Global hepatitis C elimination: an investment framework.
  Pedrana A, Howell J, Scott N, Schroeder S, Kuschel C, Lazarus JV, Atun R, Baptista-Leite R, 't Hoen E, Hutchinson SJ, Aufegger L, Peck R, Sohn AH, Swan T, Thursz M, Lesi O, Sharma M, Thwaites J, Wilson DP, Hellard M. Pedrana A, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):927-939. doi: 10.1016/S2468-1253(20)30010-8. Epub 2020 Jul 27. Lancet Gastroenterol Hepatol. 2020. PMID: 32730786 Review.

Cited by

• Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population.
  Cagnin S, Martini A, Donato D, Angeli P, Pontisso P. Cagnin S, et al. Intern Emerg Med. 2024 Apr;19(3):641-647. doi: 10.1007/s11739-023-03507-1. Epub 2024 Jan 16. Intern Emerg Med. 2024. PMID: 38227274 Free PMC article.
• Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy.
  Li Y, Yang X, Plummer R, Hayashi Y, Deng XS, Nie YZ, Taniguchi H. Li Y, et al. Int J Mol Sci. 2021 Sep 28;22(19):10471. doi: 10.3390/ijms221910471. Int J Mol Sci. 2021. PMID: 34638810 Free PMC article. Review.
• Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals.
  Kishta S, Tabll A, Omanovic Kolaric T, Smolic R, Smolic M. Kishta S, et al. Biomedicines. 2020 Jun 25;8(6):175. doi: 10.3390/biomedicines8060175. Biomedicines. 2020. PMID: 32630610 Free PMC article. Review.
• Evaluation of antiviral - passive - active immunization ("sandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice.
  Shi B, Wu Y, Wang C, Li X, Yu F, Wang B, Yang Z, Li J, Liang M, Wen Y, Ying T, Yuan Z. Shi B, et al. EBioMedicine. 2019 Nov;49:247-257. doi: 10.1016/j.ebiom.2019.10.043. Epub 2019 Nov 1. EBioMedicine. 2019. PMID: 31680000 Free PMC article.
• HBV-Induced Immune Imbalance in the Development of HCC.
  Chen Y, Tian Z. Chen Y, et al. Front Immunol. 2019 Aug 27;10:2048. doi: 10.3389/fimmu.2019.02048. eCollection 2019. Front Immunol. 2019. PMID: 31507621 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information